| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2004 | CN1515586A Diisopropoxyphosphorylated dipeptide methyl ester, its preparation and application |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515550A Thrombosis resisting preparation |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515318A Modified factor VII |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515315A Stable composition containing epidermal growth factor and bletilla tuber extract |
| 07/28/2004 | CN1515314A Human liver regeneration related protein and its application |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/28/2004 | CN1159340C Martentoxin as one great-conductance calcium-activating potassium channel blocker and its prepn and use |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159288C Protein modifier, preparation method and use thereof |
| 07/28/2004 | CN1159063C Application of bone morphogenesis protein(BMP) as medicine for acute aplastic anemia |
| 07/28/2004 | CN1159062C Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 07/28/2004 | CN1159061C Treatment of infarcts through inhibition of NF-KAPPAB |
| 07/28/2004 | CN1159003C Locally-used weight reducing face-care compsns. |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767994 Used in purification of apolipoprotein a (apoa) or apolipoprotein e; apoa or apoe produced by the process can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases |
| 07/27/2004 | US6767991 Peptides and analogs thereof; viral protease inhibitors, pharmaceutical compositions containing such peptides and ribavirin |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767897 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/27/2004 | US6767896 Polypeptide analgesics from snail venom |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767893 Method of treating conditions associated with intestinal ischemia/reperfusion |
| 07/27/2004 | US6767892 Insulin-like growth factor-1 is solubilized with guanidinium compound |
| 07/27/2004 | US6767891 Peptides of from 28 to 44 amino acids, including therein a sequence of l-k-e-k-k, have physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity |
| 07/27/2004 | US6767890 Administering leu-pro-pro-ser-arg pentapeptide |
| 07/27/2004 | US6767887 Peptides that stimulate release of insulin; treating diabetes |
| 07/27/2004 | US6767741 Metal binding compounds and their use in cell culture medium compositions |
| 07/27/2004 | US6767739 For therapy of atherosclerosis, cardiovascular disease, abnormal cholesterol metabolism, abnormal lipid metabolism |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767727 For treatment of genetic disorders; targets for competitive binding assays; drug screening |
| 07/27/2004 | US6767722 Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 |
| 07/27/2004 | US6767720 Protein-protein or protein-dna interactions in a signal transduction or transcriptional pathway controlling cell growth/development in a wide range of cells; drug discovery, diagnosis and treatment of cancer and neurological disorders |
| 07/27/2004 | US6767718 Lipodepsipeptide antibiotics and methods of preparation |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767564 Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767545 Composition for use in treating or preventing infection by pseudomonas aeruginosa comprising a p. aeruginosa pilin protein having an n-terminal peptide region modified to prevent self assembly of the peptide |
| 07/27/2004 | US6767544 Methods for treating cardiovascular diseases with botulinum toxin |
| 07/27/2004 | US6767540 Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease |
| 07/27/2004 | US6767539 Method of treating viral hemorrhagic fever |
| 07/27/2004 | US6767538 Killing grampositive bacteria |
| 07/27/2004 | US6767535 Suppressing tumor formation using cells expressing JE/monocyte chemoattractant protein-1 |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2129261C Processes of producing amylase inhibitors |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061456A2 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | WO2004061423A2 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | WO2004061408A2 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 07/22/2004 | WO2004061107A1 Cell growth inhibitor using sphingosine kinase 2, method of constructing fused protein having its nuclear localization signal, method of screening drug candidate, and screening kit |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061105A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061096A1 Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
| 07/22/2004 | WO2004061081A2 Sirna compounds and methods for the downregulation of gene expression |
| 07/22/2004 | WO2004061079A2 Candida kefyr cytosine deaminase |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060914A1 A human liver regeneration associated protein and the use of it |
| 07/22/2004 | WO2004060911A2 Combination therapy with co-stimulatory factors |
| 07/22/2004 | WO2004060910A2 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 07/22/2004 | WO2004060908A2 Method to increase fibronectin |
| 07/22/2004 | WO2004060907A2 Compounds that bind p2y2 or p2y1 receptors |
| 07/22/2004 | WO2004060425A2 Compositions and methods of using collagen and mmpi |
| 07/22/2004 | WO2004060408A1 p53 TREATMENT OF PAPILLOMAVIRUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
| 07/22/2004 | WO2004060395A1 Agent for improving life expectancy in therapy of malignant tumor |
| 07/22/2004 | WO2004060393A2 Cutaneous metabolic bio-activator |
| 07/22/2004 | WO2004060392A1 Lactoferrin protein with iron for treating iron deficiency and anemia |
| 07/22/2004 | WO2004060391A1 Use of somatostatin analogs in sleep apnea |
| 07/22/2004 | WO2004060390A2 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 07/22/2004 | WO2004060389A1 1-desamino-8-d-arginyl vasopressin analogs |
| 07/22/2004 | WO2004060388A1 Composition for preventing the formation of new scar comprising bmp-7 |
| 07/22/2004 | WO2004060387A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/22/2004 | WO2004060386A1 Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |
| 07/22/2004 | WO2004060384A2 Pharmaceutical botulinum toxin compositions |
| 07/22/2004 | WO2004060322A2 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| 07/22/2004 | WO2004060319A2 Immunostimulatory combinations |
| 07/22/2004 | WO2004060312A2 Topical composition and methods for treatment of aged or environmentally damaged skin |
| 07/22/2004 | WO2004060310A2 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | WO2004060309A2 Methods of treating and/or preventing autoimmune diseases |
| 07/22/2004 | WO2004060307A2 Synthetic neutropoiesis-stimulating proteins |
| 07/22/2004 | WO2004060300A2 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/22/2004 | WO2004060299A2 Polymer conjugates of interferon-beta with enhanced biological potency |
| 07/22/2004 | WO2004060291A2 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | WO2004060284A2 Method of using colloidal metal-protein composition for treatment of cancer |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060275A2 Wound care compositions |
| 07/22/2004 | WO2004060274A2 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| 07/22/2004 | WO2004060272A2 Delivery of peroxide-generating enzymes to the vaginal tract |